HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by King, S. B. Search for Related Content PubMed PubMed Citation Articles by King, S. B., III

Eight-year mortality in the Emory Angioplasty versus Surgery Trial (EAST)

Spencer B. King, III, MD, MACC^*, Andrzej S. Kosinski, PhD, Robert A. Guyton, MD, FACC, Nicholas J. Lembo, MD, FACC^*, William S. Weintraub, MD, FACC^* for the Emory Angioplasty Versus Surgery Trial (EAST) Investigators

^* Emory University School of Medicine, Department of Medicine, Division of Cardiology, Atlanta, Georgia, USA
Emory University School of Medicine, Department of Surgery, Division of Cardiothoracic Surgery, Atlanta, Georgia, USA
Emory University School of Medicine, Department of Biostatistics, Emory University School of Public Health, Atlanta, Georgia, USA

View larger version (18K): [in a new window]   Figure 1 Survival of all EAST patients after initial treatment with CABG or PTCA. The number of patients at risk and the estimated probability of survival at 3, 5, 7 and 8 years are shown below the figure. CABG = coronary artery bypass grafting; EAST = Emory Angioplasty versus Surgery Trial; PTCA = percutaneous transluminal coronary angioplasty.

View larger version (22K): [in a new window]   Figure 2 Survival of patients with three-vessel coronary disease (Panel A) and patients with two-vessel coronary disease (Panel B). The number of patients at risk and the estimated probability of survival at 3, 5, 7 and 8 years are shown below the figure. CABG = coronary artery bypass grafting; PTCA = percutaneous transluminal coronary angioplasty.

View larger version (18K): [in a new window]   Figure 3 Survival of patients with proximal left anterior descending stenosis. The number of patients at risk and the estimated probability of survival at 3, 5, 7 and 8 years are shown below the figure. CABG = coronary artery bypass grafting; PTCA = percutaneous transluminal coronary angioplasty.

View larger version (19K): [in a new window]   Figure 4 Survival of treated diabetic patients (Panel A), patients with initial PTCA treatment (Panel B) and patients without treated diabetes (Panel C). The number of patients at risk and the estimated probability of survival at 3, 5, 7 and 8 years are shown below the figure. CABG = coronary artery bypass grafting; PTCA = percutaneous transluminal coronary angioplasty.

View larger version (21K): [in a new window]   Figure 5 Percent of patients free from cardiac death for all EAST patients (Panel A) and for patients with three-vessel coronary disease (Panel B). The number of patients at risk and the estimated probability of freedom from cardiac death at 3, 5, 7 and 8 years are shown below the figure. CABG = coronary artery bypass grafting; PTCA = percutaneous transluminal coronary angioplasty.

View larger version (18K): [in a new window]   Figure 6 Percent of all EAST patients with subsequent PTCA (Panel A), with subsequent CABG (Panel B) and with subsequent CABG or PTCA (Panel C) after the initial revascularization procedure. The number of patients at risk and the estimated probability of the first subsequent procedure at 3, 5, 7 and 8 years are shown below the figure. CABG = coronary artery bypass grafting; PTCA = percutaneous transluminal coronary angioplasty.